NM_002485.5:c.1397+3C>G

Variant summary

Our verdict is Likely benign.
-3 Likely Benign
-7
-6
-1
0
+5
+6
+9
+10
B
LB
VUS
LP
P
The variant received -3 classification points (ACMG Germline Pathogenicity v2019). PM2BP4_StrongBP6

The NM_002485.5(NBN):c.1397+3C>G variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a cumulative frequency of 0.00000434 (AC=7) in the gnomAD database across 1,612,988 control chromosomes (no homozygotes observed). The grpmax filtering allele frequency (95% CI) is 0.0000132. In-silico predictor (BayesDel (noAF)) classifies this variant as likely benign. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign/Likely Benign (no review stars).

Frequency

Genomes: 𝑓 0.000013 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0000034 ( 0 hom. )

Consequence

NBN
NM_002485.5 splice_region, intron

Scores

3
Splicing: ADA: 0.00002728
2

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:3B:2

Conservation

PhyloP100: 0.995

Publications

0 publications found
Variant links:
Genes affected
NBN (HGNC:7652): (nibrin) Mutations in this gene are associated with Nijmegen breakage syndrome, an autosomal recessive chromosomal instability syndrome characterized by microcephaly, growth retardation, immunodeficiency, and cancer predisposition. The encoded protein is a member of the MRE11/RAD50 double-strand break repair complex which consists of 5 proteins. This gene product is thought to be involved in DNA double-strand break repair and DNA damage-induced checkpoint activation. [provided by RefSeq, Jul 2008]
NBN Gene-Disease associations (from GenCC):
  • Nijmegen breakage syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Natera, Orphanet, G2P, Myriad Women's Health, ClinGen, PanelApp Australia, Labcorp Genetics (formerly Invitae)
  • rhabdomyosarcoma
    Inheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp
  • idiopathic aplastic anemia
    Inheritance: AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
  • prostate cancer
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
  • familial ovarian cancer
    Inheritance: Unknown Classification: LIMITED Submitted by: Natera
  • hereditary breast carcinoma
    Inheritance: Unknown, AD Classification: NO_KNOWN Submitted by: Natera, ClinGen

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_002485.5, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

Classification according to ACMG Germline Pathogenicity v2019

Classification was made for transcript

Our verdict: Likely_benign. The variant received -3 points.

PM2
Very rare in gnomAD for AD/XL gene (popmax AF < threshold/10) — PM2; GnomAD popmax AF = 0.0000132 — very rare for AD+AR gene (base 0.0001, raised to 0.000225 by highest known P/LP ClinVar AF 0.000225) — PM2 moderate.
BP4
Computational evidence supports benign — no pathogenic computational or splicing signal (BP4); Splicing verdict: benign (Strong).; Germline computational verdict: benign (Strong).
BP6
ClinVar 0-star benign — supporting (BP6); ClinVar germline classification: Benign/Likely Benign, 0 star(s).

Variant Effect in Transcripts

Automated classification analysis was done for transcript: NM_002485.5. You can select a different transcript below to see updated classification assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
NBN
NM_002485.5
MANE Select
c.1397+3C>G
splice_region intron
N/ANP_002476.2
NBN
NM_001024688.3
c.1151+3C>G
splice_region intron
N/ANP_001019859.1A0A0C4DG07
NBN
NM_001440379.1
c.1151+3C>G
splice_region intron
N/ANP_001427308.1A0A0C4DG07

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
NBN
ENST00000265433.8
TSL:1 MANE Select
c.1397+3C>G
splice_region intron
N/AENSP00000265433.4O60934
NBN
ENST00000697309.1
c.1397+3C>G
splice_region intron
N/AENSP00000513244.1A0A8V8TKY5
NBN
ENST00000697293.1
c.1397+3C>G
splice_region intron
N/AENSP00000513230.1A0A8V8TM80

Frequencies

Allele frequencies (AF), counts (AC/AN), homozygotes and coverage

Common (AF > 0.05 / Hom > 5)
Rare (AF ≤ 0.0001 / Hom ≤ 1)
Source / populationAFACHomANCoverage
Global population databases 5 sources
GnomAD3 genomes
0.0000132 2015194032
GnomAD4 exome
0.00000342 50146104832
GnomAD4 genome
0.0000132 2015194032
TOPMed (Bravo)
0.0000113
ALFA (dbGaP/dbSNP Allele Frequency Aggregator)
0.0000524 2138198
Showing 5 sources

Case/control cohorts

CohortCasesControls
AFACANAFACAN
SCHEMA
(Schizophrenia)
0.00 067850 0.00000750 1133284
Showing 1 cohortAllele count / allele number. AF is computed from the counts for ASC (not provided by the source).

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
2
1
Microcephaly, normal intelligence and immunodeficiency (3)
-
1
1
Hereditary cancer-predisposing syndrome (2)

Computational Scores

AlgorithmCalibrated predictionPredictionScore
AlphaGenome AVI
Benign-9.7
BayesDel_noAF
Benign--0.57
CADD
Benign-10
DANN
Benign-0.58
GPN-Star LLR
N/A--2.8
GPN-Star score
N/A-2.8
PhyloP100
Benign-0.99
Showing 7 of 7 scores

Splicing Scores

AlgorithmCalibrated predictionPredictionScore
dbscSNV1_ADA
Benign-0.000027
dbscSNV1_RF
Benign-0.028
Pangolin (max)
Benign-0.0
SpliceAI score (max)
Benign-
Details are displayed if max score is > 0.2
0.0
Showing 4 of 4 scores

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.